LPCN · Insider Trading
Lipocine Inc.
Every open-market purchase and sale reported by LPCN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-01 | John W. Higuchi | Director | Buy | +25,007 | +$55.04K |
| 2026-09-30 | John W. Higuchi | Director | Buy | +12,561 | +$27.13K |
| 2026-08-07 | Michael Grissinger | Director | A | +2,000 deriv. | — |
| 2026-08-07 | Michael Grissinger | Director | A | +2,000 deriv. | — |
| 2026-06-04 | Richard Dana Ono | Director | A | +1,764 deriv. | — |
| 2026-06-04 | John W. Higuchi | Director | A | +1,764 deriv. | — |
| 2026-06-04 | Jill M. Jene | Director | A | +1,764 deriv. | — |
| 2026-04-07 | John W. Higuchi | Director | Buy | +40,000 | +$81.20K |
| 2026-04-06 | John W. Higuchi | Director | Buy | +123,000 | +$252.15K |
| 2026-04-06 | Mahesh V. Patel | Chief Executive Officer | Buy | +25,000 | +$50.75K |
| 2026-04-02 | Mahesh V. Patel | Chief Executive Officer | Buy | +25,000 | +$50.50K |
| 2026-01-05 | Mahesh V. Patel | Chief Executive Officer | A | +25,000 deriv. | — |
| 2025-12-19 | Krista Fogarty | Principal Accounting Officer | A | +20,786 deriv. | — |
| 2025-12-19 | Mahesh V. Patel | Chief Executive Officer | A | +8,629 deriv. | — |
| 2025-06-05 | Richard Dana Ono | Director | A | +1,764 deriv. | — |
| 2025-06-05 | Jill M. Jene | Director | A | +1,764 deriv. | — |
| 2025-06-05 | Spyros Papapetropoulos | Director | A | +1,764 deriv. | — |
| 2025-06-05 | Jeffrey Arvin Fink | Director | A | +1,764 deriv. | — |
| 2025-06-05 | John W. Higuchi | Director | A | +1,764 deriv. | — |
| 2025-01-02 | Mahesh V. Patel | Chief Executive Officer | A | +16,371 deriv. | — |
| 2025-01-02 | Mahesh V. Patel | Chief Executive Officer | A | +10,320 deriv. | — |
| 2024-12-30 | Krista Fogarty | Principal Accounting Officer | A | +5,943 deriv. | — |
| 2024-12-30 | Mahesh V. Patel | Chief Executive Officer | A | +26,691 deriv. | — |
| 2024-06-07 | Jeffrey Arvin Fink | Director | A | +1,764 deriv. | — |
| 2024-06-07 | Spyros Papapetropoulos | Director | A | +1,764 deriv. | — |
| 2024-06-07 | Jill M. Jene | Director | A | +1,764 deriv. | — |
| 2024-06-07 | John W. Higuchi | Director | A | +1,764 deriv. | — |
| 2024-06-07 | Richard Dana Ono | Director | A | +1,764 deriv. | — |
| 2024-03-12 | Krista Fogarty | Principal Accounting Officer | A | +991 | — |
| 2024-03-12 | Mahesh V. Patel | CEO and President | A | +4,893 | — |
| 2023-05-25 | Mahesh V. Patel | CEO and President | Buy | +8,706 | +$43.79K |
| 2023-05-12 | Jill M. Jene | Director | A | +30,000 deriv. | — |
| 2023-05-12 | Jeffrey Arvin Fink | Director | A | +30,000 deriv. | — |
| 2023-05-12 | Spyros Papapetropoulos | Director | A | +30,000 deriv. | — |
| 2023-05-12 | Richard Dana Ono | Director | A | +30,000 deriv. | — |
| 2023-05-12 | John W. Higuchi | Director | A | +30,000 deriv. | — |
| 2023-03-24 | Mahesh V. Patel | CEO and President | Buy | +150,000 | +$48.00K |
| 2023-03-20 | Richard Dana Ono | Director | Buy | +4,000 | +$1.36K |
| 2023-03-17 | Mahesh V. Patel | CEO and President | Buy | +50,000 | +$16.50K |
| 2023-01-04 | Mahesh V. Patel | Chief Executive Officer | A | +300,000 deriv. | — |
| 2022-12-22 | Krista Fogarty | Principal Accounting Officer | A | +91,850 deriv. | — |
| 2022-12-22 | Mahesh V. Patel | Chief Executive Officer | A | +112,500 deriv. | — |
| 2022-11-28 | Spyros Papapetropoulos | Director | Buy | +21,739 | +$10.22K |
| 2022-11-14 | Mahesh V. Patel | CEO and President | Buy | +75,000 | +$29.25K |
| 2022-11-08 | George Nomikos | Chief Medical Officer | A | +125,000 deriv. | — |
| 2022-09-27 | Mahesh V. Patel | CEO and President | Buy | +100,000 | +$41.00K |
| 2022-06-10 | Jill M. Jene | Director | A | +22,000 deriv. | — |
| 2022-06-10 | John W. Higuchi | Director | A | +22,000 deriv. | — |
| 2022-06-10 | Spyros Papapetropoulos | Director | A | +22,000 deriv. | — |
| 2022-06-10 | Jeffrey Arvin Fink | Director | A | +22,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| John W. Higuchi | Director | 225,395 | $326.82K |
| Mahesh V. Patel | Chief Executive Officer | 160,679 | $232.98K |
| Krista Fogarty | Principal Accounting Officer | 1,727 | $2.50K |
| Spyros Papapetropoulos | Director | 1,279 | $1.85K |
| Richard Dana Ono | Director | 831 | $1.20K |
| Jeffrey Arvin Fink | Director | 386 | $560 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the LPCN quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.